摘要
目的：探讨间苯三酚联合米非司酮米索前列醇用于瘢痕子宫中期妊娠的安全性与有效性。方法：选取2012年01月～2014年12月间要求终止妊娠，剖宫产后瘢痕子宫妊娠14～18周妇女60例，B 超提示子宫瘢痕愈合良好，其中观察组30例采用间苯三酚联合米非司酮米索前列醇引产；对照组30例采用米非司酮米索前列醇引产，观察两组的引产效果及安全性。结果两组在引产总时间、术后清宫率、宫颈裂伤率、子宫破裂率比较差异有统计学意义（P ＜0．05）。两组在临产发动时间、引产成功率、产后2h 阴道出血量方面差异无统计学意义（P ＞0．05）。结论间苯三酚联合米非司酮米索前列醇用于愈合良好的瘢痕子宫中期妊娠引产安全有效。
Abstract
objective to explore the phloroglucinol combined misoprostol mifepristone for scar uterus mid pregnancy of the safety and ef ectiveness.Selection methods:from January 2012 to December 2014 to the hospital for termination of gestation,cesarean section scar uterus 14 ~18 weeks of gestation women 60 cases,ultrasound prompted uterine scar healed wel ,the obser-vation group of 30 cases with phloroglucinol combined misoprostol mifepristone induced labor;The control group 30 cases using misoprostol mifepristone induced labor,observe two groups of in-duced labor,ef icacy,and safety.Results two groups in the total induced labor time,postoperative qing rate,rate of cervical laceration,uterine rupture rate comparison dif erence was statistical-ly significant (P <0.05).Two groups at launch time,the success rate of induced labor in labor,2 h postpartum vaginal haemorrhage amount dif erences of no statistical significance (P >0. 05).Conclusion phloroglucinol combined misoprostol mifepristone for healing good scar uterus mid pregnancy induced labor is safe and ef ective.
NETL
NSTL
维普
万方数据